Avai Bio, Inc.
AVAI· OTC
AVAIAvai Bio, Inc.
Filed Aug 13, 2026 · 10-Q · 44 days after period end · 0001740797-26-000021
| Metric | Q1 2027 | Q1 2026 | Q1 2025 | Q1 2024 |
|---|---|---|---|---|
| Net Income | -$552.04K | -$487.59K | -$528.84K | -$411.52K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Avai Bio, Inc. · CIK 1740797 · Engraved from SEC EDGAR
ended Jun 30, 2026 · filed Aug 13, 2026 · 44 d after period end
